Diligence memo · auto-generated · as of July 2, 2026
MBio Diagnostics, Inc.
MBio Diagnostics, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
MBio Diagnostics, Inc. operates in Medical Devices, based in BOULDER.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
MBio Diagnostics, Inc. has raised $45M in disclosed capital across 12 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $10.0M on 2021-02-01.
Most recent recorded round closed around 2022-02-18.
Valuation (modeled)modeled
Provath models MBio Diagnostics, Inc. at approximately $77M (range $7.5M–$289M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.34× the median modeled value of Series A Medical Devices companies in 2022–2024 (13 peers) — value vs value, same stage and era. Within the normal band (134% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 10 months.
Last raise 4.4 yr ago; this sector typically re-raises about every 16 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 3.5× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 94% of Medical Devices peers (233 compared).
Modeled value ranks above 84% of those peers.
Closest niche peers: Vida Diagnostics Inc, New View Surgical, Inc., Thunder Road Surgical, Llc, Barsa Surgical Inc., Caire Health Holdings, Inc..
Peoplefiled
19 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.